Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SEELOS-THERAPEUTICS-INC-53920921/news/Seelos-Therapeutics-Doses-First-Patient-in-A-Registrational-Phase-II-III-Study-of-SLS-005-in-Spinoce-42089463/?utm_source=whatsapp&utm_medium=social&utm_campaign=share